Early last week Apple excited many and rattled others with its ResearchKit announcement. The open-source toolkit or “framework” includes disease-specific applications that patients can use to track their symptoms, and will allow researchers to gather data from iPhone users to help further medical research. While reaction has been mixed, most agree that tools that help medical science advance and make people and patients more involved are welcome innovations. But clinical research and medical research aren’t the same. Running a global clinical trial is much different than creating and delivering apps to aid research on a particular disease.